Publications by authors named "D Caceres"
Article Synopsis
- Histoplasmosis is particularly dangerous for HIV patients, especially where antiretroviral therapy is hard to get, making antigen detection assays vital for quick diagnoses and reducing mortality.
- The study assessed 27 HIV patients with histoplasmosis over 24 weeks, monitoring urinary Histoplasma antigen levels as they received treatment with amphotericin B followed by itraconazole.
- Results indicated that as antigen levels decreased, patient clinical outcomes improved, suggesting that the clarus Histoplasma GM EIA kit could effectively monitor treatment responses, despite some patients having atypical antigen patterns due to immune system responses or medication absorption issues.
Objectives: Diagnosis of HIV-associated histoplasmosis remains challenging. Our objective was to compare the performances of (1→3)-β-D-Glucan (BDG) and aspergillus galactomannan (GM) antigen for the diagnosis of HIV-associated histoplasmosis.
Methods: We performed a diagnostic accuracy study using frozen primary serum specimens issued from consecutive hospitalized people living with HIV (PLWH) and blindly tested for BDG and GM using Fungitell and PlateliaAspergillus, respectively.
Background: We aimed to evaluate changes in buccal bone thickness (BBT), buccolingual dental inclinations (BLI), and transversal widths (TW) after treatment using a passive self-ligating system.
Material And Methods: Pre- and posttreatment cone-beam computed tomography images (CBCT) of 21 Class I patients (initial mean age: 14.99 ± 1.
Cryptococcosis predominantly affects immunocompromised individuals, particularly those with advanced HIV disease, with meningitis being the most severe form and linked to high mortality. Diagnosis typically relies on rapid Cryptococcus antigen (CrAg) testing, and antigen titer quantification helps in early detection and assessing disease severity. However, conventional titer methods are often more expensive than qualitative antigen detection.
View Article and Find Full Text PDFPurpose: Malignant ureteral obstruction is generally associated with a poor disease prognosis; therefore, managing these cases is challenging. We describe our experience in treating malignant ureteral obstruction with urinary diversion and the impact of these procedures on the indication for new antineoplastic therapy and survival.
Materials And Methods: We retrospectively reviewed the data of patients with advanced cancer associated with malignant ureteral obstruction who underwent urinary diversion at three tertiary institutions between January 2013 and July 2022.